How Can Model-Informed Drug Development Accelerate Your Program?
What is model-informed drug development (MIDD), and why is it so critical to informing the…
CertaraJuly 28, 2023
ICER’s Unsupported Price Increase Report: Unfit for Policymaking
Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…
CertaraJuly 25, 2023
Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients
Find out how renal function and hypoalbuminemia alter ceftriaxone PK; current dosing remains appropriate, analysed…
CertaraJuly 24, 2023
Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling
While the concept of ‘Virtual Bioequivalence’ (VBE) using a combination of modelling, in vitro tests and integration…
CertaraJuly 21, 2023
Simcyp™ compound summaries library: What is it & why should you use it?
In the world of pharmacokinetic/dynamic (PBPK/PD) modelling, compound PBPK models are incorporated into compound files…
CertaraJuly 21, 2023
RAPS Sponsored Webcast: How to Plan for a Successful EMA Policy 0070 Submission
In September 2023, the European Medicines Agency (EMA) will reinstate their Policy 0070 requirement to…
CertaraJuly 20, 2023
Pharmacokinetic and Bioequivalence Evaluation of Single-Tablet and Separate-Tablet Regimens for Ainuovirine, Lamivudine, and Tenofovir Disoproxil Fumarate in Chinese Healthy Subjects
Explore how single‑tablet regimen matches exposure of separate tablets with comparable safety, analysed using Phoenix…
CertaraJuly 20, 2023
Change management – An important part of good manufacturing practice (GMP)
You are having a good day as a quality assurance professional at a small pharmaceutical…
CertaraJuly 14, 2023
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
PRINCETON, N.J.— July 13, 2023-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…
CertaraJuly 13, 2023
